ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Osteoarthritis"

  • Abstract Number: 1184 • ACR Convergence 2024

    Sustained Clinical Effects After a Single Intra-articular Injection of PCRX-201 for Moderate-to-Severe Osteoarthritis of the Knee

    Stanley Cohen1, Philip G Conaghan2, Marc Hochberg3, Alan Kivitz4, Nino Joy5, Derek Jackson5, Masato Nakazawa5, Mary DiGiorgi5 and Jonathan Slonin5, 1Metroplex Clinical Research Center, dallas, TX, 2Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, 3University of Maryland School of Medicine, Baltimore, MD, 4Altoona Center for Clinical Research, Duncansville, PA, 5Pacira BioSciences, Inc., Tampa, FL

    Background/Purpose: Osteoarthritis of the knee (OAK) is a common and severe disease. Current treatments provide temporary pain relief, demonstrating unmet need. PCRX-201 is a high…
  • Abstract Number: 1200 • ACR Convergence 2024

    Prevalence and Joint Involvement Patterns of Erosive and Non-erosive Hand Osteoarthritis in the General Population in China

    Jing Ye1, Yuqing Wang1, Tuo Yang2, David Hunter3, Yuqing Zhang4, Weiya Zhang5, Michael Doherty5, Jiatian Li1, wei Li1, Zeqin Wen1, Chao Zeng6, Guanghua Lei7 and Jie Wei8, 1Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China (People's Republic), 2Health Management Center, Xiangya Hospital, Central South University, Changsha, China (People's Republic), 3Sydney Musculoskeletal Health, University of Sydney, St Leonards, New South Wales, Australia, 4Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School; The Mongan Institute, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 5Academic Rheumatology, School of Medicine, University of Nottingham; Pain Centre Versus Arthritis, University of Nottingham, Nottingham, United Kingdom, 6Department of Orthopaedics, Xiangya Hospital, Central South University; Key Laboratory of Aging-related Bone and Joint Diseases Prevention and Treatment, Ministry of Education, Xiangya Hospital, Central South University; Hunan Key Laboratory of Joint Degeneration and Injury, Xiangya Hospital, Central South University; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University; Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, China (People's Republic), 7Department of Orthopaedics, Xiangya Hospital, Central South University; Key Laboratory of Aging-related Bone and Joint Diseases Prevention and Treatment, Ministry of Education, Xiangya Hospital, Central South University; Hunan Key Laboratory of Joint Degeneration and Injury, Xiangya Hospital, Central South University; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China (People's Republic), 8Department of Orthopaedics, Xiangya Hospital, Central South University; Key Laboratory of Aging-related Bone and Joint Diseases Prevention and Treatment, Ministry of Education, Xiangya Hospital, Central South University; Hunan Key Laboratory of Joint Degeneration and Injury, Xiangya Hospital, Central South University; Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, China (People's Republic)

    Background/Purpose: Erosive hand osteoarthritis (HOA) poses challenges due to its aggressive nature and limited epidemiological insights. We aimed to describe the prevalence and joint involvement…
  • Abstract Number: 1441 • ACR Convergence 2024

    Factors Associated with the Evolution of Degenerative Spinal Lesions in Axial Spondyloarthritis: 10-Year Follow-up of the DESIR Cohort

    Laura Pina Vegas1, Sofia Ramiro2, Miranda van Lunteren3, Damien Loeuille4, Esther Newsum5, Caroline Morizot6, Floris van Gaalen7, Alain SARAUX8, Pascal Claudepierre9, Antoine Feydy10, Desiree van der Heijde11 and Monique Reijnierse1, 1Leiden University Medical Center, Leiden, Netherlands, 2Leiden University Medical Center, Bunde, Netherlands, 3Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands, 4Phd, Nancy Vandoeuvre, Lorraine, France, 5Nij Smellinghe, Drachten, Netherlands, 6Nancy University hospital, Nancy, France, 7LUMC, Leiden, Zuid-Holland, Netherlands, 8CHU Brest, Brest, France, 9CHU Henri Mondor, AP-HP/EpiDermE, UPEC, Créteil, France, 10CHU Cochin, AP-HP, Paris, France, 11Department of Rheumatology, Leiden University Medical Center, Meerssen, Netherlands

    Background/Purpose: Radiographs and MRI are both used to diagnose axial spondyloarthritis (axSpA) but they also provide information about morphological and even biomechanical changes in the…
  • Abstract Number: 1946 • ACR Convergence 2024

    Shaping the Future of the National Musculoskeletal (MSK) Triage Initiative: Exploring the Impact of a Hybrid Model (Virtual and Face to Face) of MSK Triage

    Julie Sugrue, Scott Murphy, Mark Kingston, paula Wallace, Catriona O'Dwyer, colum Moloney, Olivia McKenna, Finbarr Condon and Sean McKenna, Health Service Executive, Limerick, Limerick, Ireland

    Background/Purpose: Rheumatic and musculoskeletal diseases (RMDs) are the leading contributor of disability worldwide (de Thurah et al 2022). The National Musculoskeletal (MSK) Triage Initiative, ensures…
  • Abstract Number: 2096 • ACR Convergence 2024

    A Model Based on Clinical and Molecular Data Predcits the Risk of Total Joint Replacement Progression in Knee OA Patients from the OAI

    Ignacio Rego-Perez1, Alejandro Duran-Sotuela2, Jorge Vazquez-Garcia2, Cristina Ruiz-Romero3, Valentina Calamia2, Carlota Fraga-Seijas4, Vanesa Balboa-Barreiro5, Sara Relaño2, María C. De Andrés2, Lucia Lourido2, Rocio Paz-Gonzalez2, Patricia Quaranta2, Patricia Fernández-Puente2, Nicola Veronese6, Natividad Oreiro7 and francisco J Blanco8, 1Instituto de Investigacion Biomedica de A Coruña-SERGAS, A Coruña, Spain, 2Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, A Coruña, Spain, 3INIBIC - CHUAC, A Coruña, Spain, 4INIBIC, A Coruña, Spain, 5Unidad de Epidemiología Clínica y Bioeostadística. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC)., A Coruña, Spain, 6Geriatric Unit, Department of Internal Medicine and Geriatrics, University of Palermo, Via del Vespro, 141, 90127, Palermo, Italy, A Coruña, Spain, 7CHUAC, La Coruna, Galicia, Spain, 8INIBIC-University of A Coruña, A Coruña, Spain

    Background/Purpose: There is a need to design models that predict the risk of total joint replacement (TJR) in patients with knee osteoarthritis (OA). Our aim…
  • Abstract Number: 2158 • ACR Convergence 2024

    An MVPA Is MVPA Is MVPA, or Is It? Impact of the Definition of Moderate to Vigorous Physical Activity (MVPA) on Its Amount in Persons with Advanced Knee Osteoarthritis

    Samantha Chin1, Jamie Collins1, Jeffrey Katz2, Dorothy Dunlop3, Lauren Mitchell1, Rowland Chang4, Khara James1, Christine Pellegrini5, Jason Kim6, Katharine Fox1, Anne Holleman1 and Elena Losina1, 1Brigham and Women's Hospital, Boston, MA, 2Brigham and Women's Hospital, Brookline, MA, 3Northwestern University, New Haven, CT, 4Northwestern University Division of Rheumatology, Chicago, IL, 5University of South Carolina, Columbia, SC, 6Arthritis Foundation, Atlanta, GA

    Background/Purpose: ActiGraph is a gold standard for MVPA assessment with several counts per minute (CPM) validated thresholds proposed to measure MVPA. Historically, these thresholds have…
  • Abstract Number: 0031 • ACR Convergence 2024

    Beyond Pain and Inflammation: Intra-articular Liraglutide’s Comprehensive Benefits on Synovial Health and Cartilage in Osteoarthritis Compared to Dexamethasone

    Coralie Meurot1, Celine Martin1, Margot Vieubled1, Jerome Breton1, Indira Toillon2, Revital Rattenbach3 and Francis Berenbaum2, 14Moving Biotech, lille, France, 2Sorbonne University, Paris, France, 34Moving Biotech, Paris, France

    Background/Purpose: Osteoarthritis (OA) is an age-related joint disease that causes chronic pain and limited mobility. Patients mainly have access to therapies aimed at reducing inflammation…
  • Abstract Number: 0863 • ACR Convergence 2024

    The Development of Future Radiographic Knee Osteoarthritis Can Be Predicted by Peripheral Blood Epigenetic Models

    Cindy Miranda1, Nicholas Hannebutt2, Gabby dyson3, Montana Barrett4, Aleksander Szymczak3 and Matlock Jeffries3, 1Oklahoma Medical Research Foundation, Yukon, OK, 2Oklahoma Medical Research Foundation, Spencer, OK, 3Oklahoma Medical Research Foundation, Oklahoma City, OK, 4University of Oklahoma, Cement, OK

    Background/Purpose: Knee osteoarthritis (OA) is a heterogeneous disease characterized by a variety of clinical and molecular phenotypes. However, we do not yet have robust biomarkers…
  • Abstract Number: 1185 • ACR Convergence 2024

    Walking Is Associated with Less Knee Pain: A Cross-sectional Study from the Osteoarthritis Initiative

    Sydney Tran1, Jeffrey Driban2, Timothy McAlindon3, Andrea Kriska4, Bonny Rockette-Wagner4, Charles Eaton5, Marc Hochberg6, Kent Kwoh7, Michael Nevitt8 and Grace Lo9, 1Baylor College of Medicine, Houston, 2University of Massachusetts Chan Medical School, Worcester, MA, 3University of Massachusetts Chan Medical School, Worcester, 4University of Pittsburgh, Pittsburgh, PA, 5Warren Alpert Medical School of Brown University, Providence, RI, 6University of Maryland School of Medicine, Cambridge, MD, 7University of Arizona, Tucson, AZ, 8University of California, San Francisco, San Francisco, CA, 9Baylor College of Medicine / MEDVAMC, Houston, TX

    Background/Purpose: Osteoarthritis (OA) is the most common form of arthritis, with the knee being the most common joint involved. Exercise is a leading non-pharmacological treatment…
  • Abstract Number: 1201 • ACR Convergence 2024

    Association of COVID-19 Vaccinations with Osteoarthritis Flares: A Case-Crossover Study

    Minerva Nong1, Colby Lewis V2, Genna Braverman3, Vivian Bykerk3, Nathaniel Hupert2, Medha Barbhaiya3 and Lisa Mandl3, 1Hospital for Special Surgery, Tampa, FL, 2Weill Cornell Medicine, New York, NY, 3Hospital for Special Surgery, New York, NY

    Background/Purpose: People with osteoarthritis (OA) commonly experience periods of increased pain and stiffness (“flares”), which can be distressing and disabling. Despite the prevalence of OA…
  • Abstract Number: 1442 • ACR Convergence 2024

    Relationship Between Degenerative Lesions over Time in Axial Spondyloarthritis: 10-year Follow-up of the DESIR Cohort

    Laura Pina Vegas1, Floris van Gaalen2, Miranda van Lunteren3, Damien Loeuille4, Caroline Morizot5, Esther Newsum6, Pascal Claudepierre7, Alain SARAUX8, Antoine Feydy9, Monique Reijnierse1, Desiree van der Heijde10 and Sofia Ramiro11, 1Leiden University Medical Center, Leiden, Netherlands, 2LUMC, Leiden, Zuid-Holland, Netherlands, 3Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands, 4Phd, Nancy Vandoeuvre, Lorraine, France, 5Nancy University hospital, Nancy, France, 6Nij Smellinghe, Drachten, Netherlands, 7CHU Henri Mondor, AP-HP/EpiDermE, UPEC, Créteil, France, 8CHU Brest, Brest, France, 9CHU Cochin, AP-HP, Paris, France, 10Department of Rheumatology, Leiden University Medical Center, Meerssen, Netherlands, 11Leiden University Medical Center, Bunde, Netherlands

    Background/Purpose: Spinal degenerative lesions (DLs) are commonly seen/reported in radiographs and MRI in axSpA. However, the relationship between the different DLs over time has not…
  • Abstract Number: 1947 • ACR Convergence 2024

    Optimizing Osteoarthritis Care Through Clinical and Community Partnership: Results of an Exploratory Trial

    Kelli Allen1, Liubov Arbeeva2, Leigh Callahan3, Katherine Combs4, Tamara Godfrey5, Yvonne Golightly6, Derek Hales5, Carla Hill7, Katie Huffman8, Amanda Nelson5, Jennifer Rees5 and Todd Schwartz9, 1University of North Carolina, Durham, NC, 2University of North Carolina, Chapel Hill, Carrboro, NC, 3University of North Carolina Thurston Arthritis Research Center, Chapel Hill, NC, 4YMCA of the Triangle, Raleigh, NC, 5University of North Carolina at Chapel HIll, Chapel Hill, NC, 6University of Nebraska Medical Center, Omaha, NE, 7UNC Health, Raleigh, NC, 8UNC Thurston Arthritis Research Center, Chapel Hill, NC, 9University of North Carolina-Chapel Hill, Chapel Hill, NC

    Background/Purpose: Many studies have documented gaps in quality of care for knee and hip osteoarthritis (OA), particularly with respect to lifestyle (e.g., weight management, exercise)…
  • Abstract Number: 2097 • ACR Convergence 2024

    Application of Machine Learning Methods to Predict the Risk of Rapid Pain Progression in Patients with Knee OA. Study Using Patients from the OAI and PROCOAC

    Ignacio Rego-Perez1, Isabel Rodriguez-Valle2, Juan Fernández-Tajes2, Vanesa Balboa-Barreiro3, Carlota Fraga-Seijas2, María del carmen de andres2, Valentina Calamia2, Patricia Fernández-Puente4, Nicola Veronese5, Cristina Ruiz-Romero6, Natividad Oreiro7 and francisco J Blanco8, 1Instituto de Investigacion Biomedica de A Coruña-SERGAS, A Coruña, Spain, 2Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña UDC. As XUbias, 15006. A Coruña, España, A Coruña, Spain, 3Unidad de Epidemiología Clínica y Bioeostadística. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC)., A Coruña, Spain, 4Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, A Coruña, Spain, 5Geriatric Unit, Department of Internal Medicine and Geriatrics, University of Palermo, Via del Vespro, 141, 90127, Palermo, Italy, A Coruña, Spain, 6INIBIC - CHUAC, A Coruña, Spain, 7CHUAC, La Coruna, Galicia, Spain, 8INIBIC-University of A Coruña, A Coruña, Spain

    Background/Purpose: There is a need to design models based on machine learning that are capable of predicting the risk of rapid pain progression of knee…
  • Abstract Number: 2271 • ACR Convergence 2024

    Intra-Articular Injection of Human Bone Marrow-Derived Mesenchymal Stem Cells in Knee Osteoarthritis: A Randomized, Double-Blind, Controlled Trial

    Jennifer Lee1 and Ji Hyeon Ju2, 1seoul st mary's hospital, Seoul, South Korea, 2Seoul St MAry's hospital, Seoul, Republic of Korea

    Background/Purpose: To assess the impact of a single intra-articular (IA) injection of bone marrow-derived mesenchymal stem cells (BM-MSCs) in patients with knee osteoarthritis (OA).Methods: This…
  • Abstract Number: L04 • ACR Convergence 2023

    EP-104IAR (Extended-Release Fluticasone Propionate for Injectable Suspension): Topline and Key Secondary Results from a Phase 2 Randomized, Double-blind, Vehicle-Controlled Trial in Subjects with Knee Osteoarthritis

    James Helliwell1, Amanda Malone1, Mark Kowalski2, Asger Reinstrup Bihlet3, Claire Miller4, Alejandro Castillo Mondragon5, Yanqi Li6, Christine Dobek7, Vik Peck1, Mike Wilmink8 and Lee Simon9, 1Eupraxia Pharmaceuticals, Victoria, BC, Canada, 2Eupraxia Pharmaceuticals, Winchester, VA, 3NBCD A/S, Soeborg, Denmark, 4NBCD A/S, Copenhagen, Denmark, 5NBCD, Copenhagen, Denmark, 6NBCD A/S, Soborg, Denmark, 7Eupraxia Pharmaceuticals, Edmonton, AB, Canada, 8OrthoArizona, Phoenix, AZ, 9SDG LLC, Cambridge, MA

    Background/Purpose: EP-104IAR is being developed to treat OA symptoms. Previous results from non-clinical studies evaluating local joint safety in beagle dogs, in contrast to other…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 71
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology